Ranibizumab

Category: Vision / Eye Health



Ranibizumab Overview

Ranibizumab (trade name Lucentis among others) is a monoclonal antibody fragment (Fab) created from the same parent mouse antibody as bevacizumab. It is an anti-angiogenic that has been approved to treat the "wet" type of age-related macular degeneration (AMD, also ARMD), a common form of age-related vision loss. Ranibizumab was developed by Genentech and marketed by them in the United States, and elsewhere by Novartis,[2] under the brand name Lucentis. Contents 1 Medical us...

Read more Ranibizumab Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Ranibizumab

Recent Ranibizumab Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Ranibizumab
  • Injection: 0, 10mg/ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Ranibizumab or a similar ingredient: (1 result)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 4 December 2020.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA